Teladoc Health, Inc.
TDOC
$7.68
$0.496.82%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.54B | 2.55B | 2.57B | 2.59B | 2.61B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.54B | 2.55B | 2.57B | 2.59B | 2.61B |
| Cost of Revenue | 756.04M | 753.56M | 751.27M | 755.77M | 761.98M |
| Gross Profit | 1.79B | 1.80B | 1.82B | 1.83B | 1.85B |
| SG&A Expenses | 1.32B | 1.33B | 1.35B | 1.33B | 1.34B |
| Depreciation & Amortization | 359.96M | 363.53M | 373.55M | 381.55M | 386.28M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.73B | 2.74B | 2.78B | 2.79B | 2.82B |
| Operating Income | -183.49M | -186.65M | -208.79M | -196.55M | -214.68M |
| Income Before Tax | -232.36M | -1.03B | -993.65M | -970.86M | -997.92M |
| Income Tax Expenses | -25.00M | -13.35M | 7.59M | 10.87M | 7.61M |
| Earnings from Continuing Operations | -207.36 | -1.01K | -1.00K | -981.73 | -1.01K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -207.36M | -1.01B | -1.00B | -981.73M | -1.01B |
| EBIT | -183.49M | -186.65M | -208.79M | -196.55M | -214.68M |
| EBITDA | 18.88M | 32.82M | 31.72M | 63.58M | 63.36M |
| EPS Basic | -1.19 | -5.93 | -5.88 | -5.78 | -5.93 |
| Normalized Basic EPS | -0.53 | -0.57 | -0.67 | -0.58 | -0.68 |
| EPS Diluted | -1.19 | -5.93 | -5.88 | -5.78 | -5.93 |
| Normalized Diluted EPS | -0.53 | -0.57 | -0.67 | -0.58 | -0.68 |
| Average Basic Shares Outstanding | 694.33M | 688.65M | 682.22M | 675.52M | 669.14M |
| Average Diluted Shares Outstanding | 694.33M | 688.65M | 682.22M | 675.52M | 669.14M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |